12:55 PM EDT, 03/19/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We trim our 12-month target price to USD41 from USD49. Our valuation is based on a reduced P/E multiple of 12.8x (15.2x previously) applied to our unchanged 2026 EPS forecast. This reflects a higher equity risk premium in the current environment of heightened geopolitical uncertainty and a more cautious market backdrop. UBS has successfully completed the large-scale migration of Credit Suisse clients onto its Swiss platform, an exercise management had flagged as the most complex phase of the integration. We see this as materially reducing execution risk, marking a transition from integration to delivery. The recent share price correction has improved valuation support but appears largely led by broader market factors rather than a material change in underlying fundamentals. With regulatory uncertainty still elevated and limited near-term catalysts beyond the upcoming capital framework decision, we see the risk-reward as broadly balanced at current levels. We maintain our Hold rating.